Carroll Financial Associates’s Repligen RGEN Stock Holding History

Carroll Financial Associates’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$310K	Sell	1,160 -9	-0.8%	-$2.42K	0.02%	315
2021 Q3	$337K	Buy	1,169 +159	+16%	+$40.8K	0.02%	300
2021 Q2	$201K	Buy	1,010 +10	+1%	+$1.94K	0.01%	409
2021 Q1	$194K	Hold	1,000	–	–	0.01%	401
2020 Q4	$191K	Hold	1,000	–	–	0.01%	372
2020 Q3	$147K	Hold	1,000	–	–	0.01%	402
2020 Q2	$123K	Hold	1,000	–	–	0.01%	433
2020 Q1	$96K	Hold	1,000	–	–	0.01%	432
2019 Q4	$92K	Hold	1,000	–	–	0.01%	518
2019 Q3	$76K	Hold	1,000	–	–	0.01%	557
2019 Q2	$85K	Hold	1,000	–	–	0.01%	520
2019 Q1	$59K	Hold	1,000	–	–	0.01%	535
2018 Q4	$53K	Hold	1,000	–	–	0.01%	479
2018 Q3	$55K	Hold	1,000	–	–	0.01%	488
2018 Q2	$47K	Hold	1,000	–	–	0.01%	510
2018 Q1	$36K	Buy	+1,000	New	+$35.2K	﹤0.01%	549

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Carroll Financial Associates's RGEN Position: Q4 2021 in Review

Carroll Financial Associates reduced its Repligen (RGEN) stake by 0.77% in Q4 2021, selling an estimated $2.42K and leaving 1,160 shares worth $310K. The position accounts for 0.02% of the portfolio, ranked #315.

Carroll Financial Associates first reported a position in RGEN in Q1 2018 and has held it in 16 quarters since. The position peaked at $337K in Q3 2021. 508 funds tracked by Wall St. Rank hold RGEN as of Q4 2021.

Carroll Financial Associates held 1,160 shares of Repligen worth $310K as of Q4 2021.
Carroll Financial Associates sold 9 Repligen shares in Q4 2021, an estimated $2.42K.
Repligen made up 0.02% of Carroll Financial Associates's portfolio in Q4 2021, its #315 holding.
Carroll Financial Associates first reported a position in Repligen in Q1 2018 and has held it in 16 quarters since.
Carroll Financial Associates's Repligen position peaked at $337K in Q3 2021.
508 funds tracked by Wall St. Rank held Repligen as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.